Choroidal and skin metastases from colorectal cancer

World J Gastroenterol. 2016 Nov 21;22(43):9650-9653. doi: 10.3748/wjg.v22.i43.9650.

Abstract

Choroidal and skin metastasis of colon cancer is rare. In women, the frequency of cutaneous metastasis from colon cancer as the primary lesion in is 9% and skin metastasis occurs in 0.81% of all colorectal cancers. We report a patient with colonic adenocarcinoma who presented with visual disorder in her right eye and scalp pain as her initial symptoms. Contrast-enhance orbital magnetic resonance imaging with fat suppression revealed an infrabulbar mass, and skin biopsy of the posterior parietal scalp confirmed adenocarcinoma. These symptoms were diagnosed as being caused by choroidal and skin metastases of colonic adenocarcinoma. We started palliative chemotherapy with oral capecitabine (1000 mg/m2, twice a day, on days 1-14) every 3 wk, which was effective at shrinking the brain masses and improving the visual disorder. This is the first report that capecitabine is effective at reducing a choroidal and cutaneous metastatic lesion from right-sided colorectal cancer.

Keywords: Capecitabine; Choroid cancer; Colon cancer; Skin cancer.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary*
  • Administration, Oral
  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage
  • Biopsy
  • Capecitabine / administration & dosage
  • Choroid Neoplasms / diagnostic imaging
  • Choroid Neoplasms / drug therapy
  • Choroid Neoplasms / secondary*
  • Colorectal Neoplasms / diagnostic imaging
  • Colorectal Neoplasms / pathology*
  • Disease Progression
  • Drug Administration Schedule
  • Fatal Outcome
  • Female
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / secondary*
  • Humans
  • Magnetic Resonance Imaging
  • Scalp / pathology*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / secondary*
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tumor Burden

Substances

  • Antimetabolites, Antineoplastic
  • Capecitabine